World Hepatitis Day 2026: Health Ministry marks eight years of National Viral Hepatitis Control Programme
On World Hepatitis Day, 28 July 2026, the Health Ministry marked eight years of the National Viral Hepatitis Control Programme under the global theme 'Hepatitis: Let's Break It Down'.
Summary
The Union Health Ministry observed World Hepatitis Day 2026 under the global theme 'Hepatitis: Let's Break It Down', marking eight years of the National Viral Hepatitis Control Programme (NVHCP), launched on World Hepatitis Day 2018 under the National Health Mission. NVHCP aims to eliminate viral hepatitis as a public health threat by 2030, in line with SDG Target 3.3. MoS Anupriya Patel said Hepatitis B birth-dose coverage has crossed 92% and India provides free treatment for Hepatitis C and management of Hepatitis B. Over 21 crore people have been screened, over 6 lakh treated and 1,153 treatment centres set up under NVHCP.
Key facts
- Day
- World Hepatitis Day – 28 July
- Theme 2026
- Hepatitis: Let's Break It Down
- Programme
- NVHCP – launched 2018 under NHM
- Goal
- Eliminate viral hepatitis as public health threat by 2030 (SDG 3.3)
- Hep B birth dose
- Over 92% coverage
- NVHCP reach
- 21 crore+ screened; 6 lakh+ treated; 1,153 treatment centres
Practice MCQs 2 questions
What was the global theme of World Hepatitis Day 2026?
Show answer
Correct answer: D — Hepatitis: Let's Break It Down
The Health Ministry observed World Hepatitis Day 2026 (28 July) under the global theme 'Hepatitis: Let's Break It Down'.
Consider the following statements about India's National Viral Hepatitis Control Programme (NVHCP): 1. It was launched on World Hepatitis Day in 2018 under the National Health Mission. 2. It aims to eliminate viral hepatitis as a public health threat by 2030. 3. Hepatitis B birth-dose coverage under it is still below 80%. Which of the statements given above are correct?
Show answer
Correct answer: A — 1 and 2 only
NVHCP was launched on World Hepatitis Day 2018 under NHM with a 2030 elimination goal (SDG 3.3). Hepatitis B birth-dose coverage has crossed 92%.